Myeloid NGS Panel

What is the Myeloid S5 NGS test?

The Myeloid S5 NGS test is a Next-Generation Sequencing (NGS) based genetic test used to detect mutations associated with myeloid cancers and blood disorders. It helps identify clinically relevant genetic alterations in conditions such as Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), and Myeloproliferative Neoplasms (MPN).

Why is the Myeloid S5 NGS test done?

• To identify genetic mutations linked to myeloid malignancies.
• To support diagnosis and classification of blood cancers.
• To guide targeted therapy and personalized cancer treatment.
• To assess prognosis and disease risk.
• To monitor disease progression and treatment response.

Who should get tested for the Myeloid S5 NGS test?

• Patients with suspected or confirmed myeloid cancers.
• Individuals with abnormal blood counts or bone marrow findings.
• Leukemia patients requiring molecular profiling.
• Patients advised for precision oncology testing.

More about the Myeloid S5 NGS test

Myeloid S5 NGS test is an advanced genomic test that analyses multiple cancer-related genes simultaneously using Next-Generation Sequencing technology. It helps clinicians make informed treatment decisions and supports personalized cancer care.

Other/Similar names of the test

• Myeloid Mutation Panel
• Myeloid Cancer NGS Test
• Leukemia Genetic Profiling
• Haematology NGS Panel